Two Sigma Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-35,632
Closed -$1.93M 2207
2014
Q4
$1.93M Buy
35,632
+4,192
+13% +$234K 0.01% 848
2014
Q3
$1.78M Sell
31,440
-70,216
-69% -$3.94M 0.01% 847
2014
Q2
$5.61M Buy
+101,656
New +$5.55M 0.04% 442
2014
Q1
Sell
-113,184
Closed -$5.41M 2443
2013
Q4
$5.41M Buy
113,184
+44,016
+64% +$2.01M 0.05% 370
2013
Q3
$3.14M Buy
69,168
+20,960
+43% +$957K 0.04% 452
2013
Q2
$2.14M Buy
+48,208
New +$2.15M 0.03% 489

Other funds holding MRK

Two Sigma Advisers's MRK Position: Q4 2025 in Review

Two Sigma Advisers sold out of Merck (MRK) in Q4 2025, closing a stake of 2,320,900 shares — an estimated $195M sold.

Two Sigma Advisers first reported a position in MRK in Q3 2013 and held it in 48 quarters. The position peaked at $515M in Q4 2023. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Two Sigma Advisers reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 2,320,900 Merck shares in Q4 2025, an estimated $195M.
  • Two Sigma Advisers first reported a position in Merck in Q3 2013 and held it in 48 quarters.
  • Two Sigma Advisers's Merck position peaked at $515M in Q4 2023.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.